Roche is to buy gene therapy firm Spark Therapeutics for $4.8 billion, adding an already-approved treatment for inherited blindness to its portfolio, and boosting its pipeline with a series of ...

Upcoming Movies and TV shows Rotten Tomatoes Podcast Media News + More ...